StockVS

TSX · CAD

Big Pharma Split Corp A Shares (PRM.TO) Stock Analysis

Big Pharma Split Corp A Shares (PRM.TO) is a stock listed on TSX and quoted in Canadian Dollar.

Last Updated: October 21, 2026

PRM.TO

CA$15.24

+CA$0.49 (+3.32%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PRM.TO with… →

PRM.TO Key Statistics

As of Oct 21, 2026
Trading
Open
CA$15.00
Previous Close
CA$14.75
Day's Range
15.00–15.24
52-Week Range
11.91–16.10
Volume
1.80K
Valuation
Market Cap
CA$20.01M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.95
Financials (FY)
Revenue (FY)
CA$5.55M+1,175.25%
Net Income (FY)
CA$5.03M+37,412.37%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.31M
1-Year Return
+33.31%
Dividend and dates
Avg Volume
1.61K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, PRM.TO closed at CA$15.24, +33.31% over 1 year.

Big Pharma Split Corp A Shares (PRM.TO) has a market capitalization of CA$20.01M.

In fiscal 2025, PRM.TO reported revenue of CA$5.55M.

PRM.TO Stock Return by Calendar Year

Big Pharma Split Corp A Shares (PRM.TO) return since Nov 2017: what CA$10,000 became

1 year
CA$10,000 CA$13,331
+33.31%
5 years
CA$10,000 CA$17,627
+76.27%
Since Nov 2017
CA$10,000 CA$24,879
+148.79%

If you had invested CA$10,000 in Big Pharma Split Corp A Shares (PRM.TO) at the close on November 27, 2017, the earliest close on record here, it would have been worth CA$24,879 at the close on October 21, 2026: +148.79% in total, +10.79% a year, with dividends reinvested, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+15.27%
2025+18.30%
2024+3.89%
2023+2.82%
2022+8.32%
2021+25.60%
2020+5.83%
2019+25.29%
2018−3.66%
2017 (partial year)−1.71%

As of October 21, 2026.

PRM.TO Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025CA$5.55MCA$5.03M90.5%
2024CA$435.58KCA$13.41K3.1%
2023CA$306.55K−CA$144.90K−47.3%
2022CA$3.71MCA$3.15M84.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025CA$5.55M——CA$5.03M90.5%
2024CA$435.58K——CA$13.41K3.1%
2023CA$306.55K——−CA$144.90K−47.3%
2022CA$3.71M——CA$3.15M84.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PRM.TO Dividend History

CA$1.24−5.6% vs 2024

Dividends per share, 2025 · 12 payments

YearDividends per sharePaymentsChange
2026*CA$0.828—
2025CA$1.2412−5.6%
2024CA$1.3113+5.9%
2023CA$1.2412+0.0%
YearDividends per sharePaymentsChange
2026 (partial year)CA$0.828—
2025CA$1.2412−5.6%
2024CA$1.3113+5.9%
2023CA$1.2412+0.0%
2022CA$1.2412−36.7%
2021CA$1.9513+45.8%
2020CA$1.3412+8.3%
2019CA$1.2412+0.0%
2018CA$1.2412+1,100.0%
2017CA$0.101—

Most recent payment: CA$0.10 per share, ex-dividend August 31, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

Analysis

Data-derived

Company Overview

The market values Big Pharma Split Corp A Shares (PRM.TO) at CA$20.01M.

PRM.TO last closed at CA$15.24 on October 21, 2026. That is +CA$0.49 (+3.32%) against the previous close. Over the past 52 weeks the price has ranged from CA$11.91 to CA$16.10. The latest close sits 27.96% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of CA$5.55M. That is +1,175.25% against the prior fiscal year, when revenue was CA$435.58K. Net income for the same year was CA$5.03M. That is +37,412.37% against the prior fiscal year. Trailing earnings per share are −1.95.

Across the 4 fiscal years on file, revenue moves from CA$3.71M in 2022 to CA$5.55M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative.

Over the trailing twelve months the total return is +33.31%. Across 5 years the annualized return works out at +12.00%. Annualized volatility over the trailing 8 years is 28.47%.

Growth & Income

The dividend record for PRM.TO runs through 2026. Dividends are recorded for 10 calendar years; 2026 shows 8 payments totalling CA$0.82 a share. The year before, 2025, totalled CA$1.24 a share.

2026 is still running; the total return is +15.27% year to date. The strongest complete calendar year on file is 2021 at +25.60%; the weakest is 2018 at −3.66%. Of the 8 complete calendar years on file, 7 finished higher.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.